AUROLIFE PHARMA LLC FDA Approval ANDA 204459

ANDA 204459

AUROLIFE PHARMA LLC

FDA Drug Application

Application #204459

Application Sponsors

ANDA 204459AUROLIFE PHARMA LLC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL5MG0OXYMORPHONE HYDROCHLORIDEOXYMORPHONE HYDROCHLORIDE
002TABLET;ORAL10MG0OXYMORPHONE HYDROCHLORIDEOXYMORPHONE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2016-04-26
REMS; REMSSUPPL2AP2018-09-18
LABELING; LabelingSUPPL3AP2021-02-16STANDARD
LABELING; LabelingSUPPL4AP2021-02-16STANDARD
LABELING; LabelingSUPPL5AP2021-03-04STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL3Null7
SUPPL4Null15
SUPPL5Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

AUROLIFE PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204459
            [companyName] => AUROLIFE PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXYMORPHONE HYDROCHLORIDE","activeIngredients":"OXYMORPHONE HYDROCHLORIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXYMORPHONE HYDROCHLORIDE","activeIngredients":"OXYMORPHONE HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/26\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"09\/18\/2018","submission":"SUPPL-2","supplementCategories":"REMS - PROPOSAL - D-N-A","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2018-09-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.